Androgen Deprivation Therapy for Prostate Cancer

Journal of Urology

Volumn 178, Issue 4, 2007, Pages 1148-

  Bahnson, Robert ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

CANCER GROWTH; CASTRATION; EDITORIAL; HORMONAL THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; TESTOSTERONE BLOOD LEVEL;

ANDROGEN ANTAGONISTS; DISEASE PROGRESSION; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TESTOSTERONE;

EID: 34548449816     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.07.066     Document Type: Editorial

References (2)

1. Chen C.D., Welsbie D.S., Tran C., Baek S.H., Chen R., Vessella R., et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 10 (2004) 33
2. Marhefka C.A., Gao W., Chung K., Kim J., He Y., Yin D., et al. Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators. J Med Chem 47 (2004) 993